![3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid chemical structure 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid (CAS: 314-50-1) - Chemical Structure and Molecular Formula](/static/img/prod_pic/FT-0773936.png) 
                                        ![3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid chemical structure thumbnail 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid (CAS: 314-50-1) - Chemical Structure Thumbnail](/static/img/prod_pic/FT-0773936.png) 
                                        3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid
Catalog No: FT-0773936
CAS No: 314-50-1
- Chemical Name: 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid
- Molecular Formula: C10H12N2O8
- Molecular Weight: 288.21
- InChI Key: FKCRAVPPBFWEJD-XVFCMESISA-N
- InChI: InChI=1S/C10H12N2O8/c13-2-4-6(15)7(16)8(20-4)12-3(9(17)18)1-5(14)11-10(12)19/h1,4,6-8,13,15-16H,2H2,(H,17,18)(H,11,14,19)/t4-,6-,7-,8-/m1/s1
| Assay | Pack Size | Price | Stock | Action | 
|---|---|---|---|---|
| 98% | 1g | N/A | N/A | |
| 98% | 5g | N/A | N/A | |
| 98% | Bulk Quantity | N/A | N/A | 
| Bolling_Point: | N/A | 
|---|---|
| Product_Name: | Orotidine | 
| FW: | 288.211 | 
| CAS: | 314-50-1 | 
| MF: | C10H12N2O8 | 
| Melting_Point: | 200ºC | 
| Flash_Point: | N/A | 
| Density: | 1.8±0.1 g/cm3 | 
| Refractive_Index: | 1.678 | 
|---|---|
| PSA: | 162.08000 | 
| FW: | 288.211 | 
| LogP: | -1.24 | 
| Exact_Mass: | 288.059357 | 
| MF: | C10H12N2O8 | 
| Melting_Point: | 200ºC | 
| Density: | 1.8±0.1 g/cm3 | 
| HS_Code: | 2934999090 | 
|---|---|
| Personal_Protective_Equipment: | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter | 
| RIDADR: | NONH for all modes of transport | 
 
                             
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                     
                                                    